Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis

Ann‐Christin Pecher(University Children's Hospital Tübingen), Dominik Schneidawind(University of Tübingen), Silke Duerr‐Stoerzer(University of Tübingen), Corina Schneidawind(University of Tübingen), Elisa Asteriti(University of Tübingen), Reinhild Klein(University Children's Hospital Tübingen), Felix Kettemann(University of Tübingen), Hildegard Keppeler(University of Tübingen), Kathy-Ann Secker(University of Tübingen), Hannes Schmid(University of Tübingen), Jörg Henes(University of Tübingen), Lothar Kanz(University of Freiburg), Clemens Hinterleitner(University of Tübingen)
Arthritis Research & Therapy
October 15, 2019
10.1186/s13075-019-1991-y
Cited by 12

Related Papers

Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
|Blood|1994|431
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
|Leukemia|2012|417
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
|The Lancet|2016|401
RETRACTED: Reconstitution of Hematopoiesis after High-Dose Chemotherapy by Autologous Progenitor Cells Generated ex Vivo
|New England Journal of Medicine|1995|370
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
|Blood|1994|357